Latest filing published 03 Apr 2026 for PAVmed Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Ronald M. Sparks (board member) discloses dealings in 2 companies, chiefly Lucid Diagnostics Inc. and PAVmed Inc. We count 6 filings; the first trade dates from 18 October 2021 and the latest from 2 April 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 3 April 2026, the filings show a share grant in PAVmed Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations